Sources | Names Used |
---|---|
CTRPv2 | tretinoin:navitoclax (4:1 mol/mol) |
PharmacoGx | tretinoin:navitoclax (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NEURL1B | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-07 |
mRNA | FAM13C | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-07 |
mRNA | C19orf35 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-07 |
mRNA | UTP3 | CTRPv2 | pan-cancer | AAC | -0.19 | 5e-07 |
mRNA | RALGAPA2 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-07 |
mRNA | NCKAP1L | CTRPv2 | pan-cancer | AAC | 0.25 | 5e-07 |
mRNA | NRROS | CTRPv2 | pan-cancer | AAC | 0.23 | 5e-07 |
mRNA | TARBP1 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-07 |
mRNA | DPYSL5 | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-07 |
mRNA | PODXL2 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-07 |